Terms: = Leukemia AND KCNJ5, ENSG00000120457, 3762, P48544, KIR3_4, KATP1, GIRK4
4 results:
1. Hypomethylating agent therapy use and survival in older patients with chronic myelomonocytic leukemia in the United States: A large population-based study.
Zeidan AM; Hu X; Long JB; Wang R; Ma X; Podoltsev NA; Huntington SF; Gore SD; Davidoff AJ
Cancer; 2017 Oct; 123(19):3754-3762. PubMed ID: 28621841
[TBL] [Abstract] [Full Text] [Related]
2. Association between anti-thymocyte globulin exposure and survival outcomes in adult unrelated haemopoietic cell transplantation: a multicentre, retrospective, pharmacodynamic cohort analysis.
Admiraal R; Nierkens S; de Witte MA; Petersen EJ; Fleurke GJ; Verrest L; Belitser SV; Bredius RGM; Raymakers RAP; Knibbe CAJ; Minnema MC; van Kesteren C; Kuball J; Boelens JJ
Lancet Haematol; 2017 Apr; 4(4):e183-e191. PubMed ID: 28330607
[TBL] [Abstract] [Full Text] [Related]
3. Identification of amplified genes in a patient with acute myeloid leukemia and double minute chromosomes.
Crossen PE; Morrison MJ; Rodley P; Cochrane J; Morris CM
Cancer Genet Cytogenet; 1999 Sep; 113(2):126-33. PubMed ID: 10484978
[TBL] [Abstract] [Full Text] [Related]
4. Relationship of urinary pseudouridine and 1-methyladenosine to activity of leukemia and lymphoma.
Itoh K; Konno T; Sasaki T; Ishiwata S; Ishida N; Misugaki M
Clin Chim Acta; 1992 Mar; 206(3):181-9. PubMed ID: 1606704
[TBL] [Abstract] [Full Text] [Related]
